Nyse bdx.

One of the largest of these companies is Becton, Dickinson and Co. ( NYSE: BDX) which develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products ...On Friday, Becton Dickinson and Co (BDX:NYQ) closed at 238.89, 4.49% above its 52-week low of 228.62, set on Mar 13, 2023. Data delayed at least 15 minutes, as of Nov 24 2023 18:10 GMT. Latest Becton Dickinson and Co (BDX:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Analyst Upgrades and Downgrades. BDX has been the topic of several recent analyst reports. Citigroup dropped their target price on Becton, Dickinson and Company from $282.00 to $260.00 in a report ...DUBLIN (2 June 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today held a grand opening ceremony for a new €4 million research and development facility in Blackrock, Dublin and announced an additional €30 million investment to expand its manufacturing facility in Enniscorthy, Wexford. The …

Nov 10, 2023 · Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript November 9, 2023 Becton, Dickinson and Company reports earnings inline with expectations. Reported EPS is $3.42 EPS ... JHVEPhoto/iStock Editorial via Getty Images. Becton, Dickinson (NYSE:BDX) announced the acquisition of Venclose, Inc., a company that offers therapeutic options for patients with chronic venous ...Becton, Dickinson and Company has increased its dividend for the past 51 consecutive years. When did Becton, Dickinson and Company last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.04 on Thursday, November 9, 2023.

Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based multinational medical device company. On January 24, the company announced a quarterly dividend of $0.91 per share, which was ...

Nov 10, 2023 · Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript November 9, 2023 Becton, Dickinson and Company reports earnings inline with expectations. Reported EPS is $3.42 EPS ... Apr 21, 2023 · Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based multinational medical device company. On January 24, the company announced a quarterly dividend of $0.91 per share, which was ... Jul 28, 2022 · FRANKLIN LAKES, N.J., July 28, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today it has acquired MedKeeper, a ... Becton, Dickinson (NYSE:BDX) has never been my favorite name among med-techs, but there is something to be said for a company with commanding share in many essential med-surg markets and where ...

Becton, Dickinson and Company (NYSE:BDX) is a multinational medical device company, headquartered in New Jersey, US. In January, BofA upgraded the stock to Buy with a $290 price target.

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (70.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (22.2%): automated systems for blood testing, mycobacteria detection ...

Shares of NYSE BDX traded up $2.09 during trading hours on Friday, hitting $238.89. The company’s stock had a trading volume of 780,792 shares, compared to its average volume of 1,700,525.FRANKLIN LAKES, N.J., Jan. 6, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its second annual cybersecurity ...The average twelve-month price prediction for Becton, Dickinson and Company is $283.86 with a high price target of $310.00 and a low price target of $260.00. Learn more on BDX's analyst rating history. Do Wall Street analysts like Becton, Dickinson and Company more than its competitors?FRANKLIN LAKES, N.J., April 30, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep™ skin preparation with sterile solution, the only fully sterile chlorhexidine …BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug …FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president ...Oct 6, 2022 · With its stock down 6.3% over the past month, it is easy to disregard Becton Dickinson (NYSE:BDX). However, the company's fundamentals look pretty decent, and long-term financials are usually ...

BD Names Dr. Ronald Silverman as Chief Medical Officer. BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced …Apr 1, 2022 · FRANKLIN LAKES, N.J., April 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it has completed its spinoff ... FRANKLIN LAKES, NJ (November 9, 2023) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fourth quarter and full year of fiscal 2023, which ended September 30, 2023. “We achieved another quarter, and another year, of strong performance through our …bd .com. Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. [citation needed] BD is ranked #177 in the 2021 Fortune 500 list [5] based on ...Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets. FRANKLIN LAKES, N.J., June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS (NYSE: STE) for $540 million.

Becton, Dickinson: (BDX) - A Quality Defensive Pick BDX gapping higher and may be breaking out of this 5-year range it's been trading in. This serial-acquirer is a buy. This serial-acquirer is a buy. Over the longer-term, Becton Dickinson has been a solid compounder, and the current valuation represents a reasonable entry point.

Becton, Dickinson & Co (BDX) Medical technology company Becton, Dickinson & Co (NYSE:BDX) saw shares plummet recently on weaker-than-expected guidance. The company expects revenues of between $20. ...BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and ...FRANKLIN LAKES, NJ (November 9, 2023) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fourth quarter and full year of fiscal 2023, which ended September 30, 2023. “We achieved another quarter, and another year, of strong performance through our …Becton Dickinson & Co(NYSE:BDX) recently announced a dividend of $0.91 per share, payable on 2023-09-29, with the ex-dividend date set for 2023-09-07. As investors look forward to this upcoming ...Jul 13, 2023 · Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ... One of the largest of these companies is Becton, Dickinson and Co. ( NYSE: BDX) which develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products ...Becton, Dickinson and Company (NYSE:BDX) is a global medical device company offering a broad range of medical supplies, devices, laboratory equipment, and diagnostic products used by the ...Shares of NYSE BDX traded up $2.09 during trading hours on Friday, hitting $238.89. The company’s stock had a trading volume of 780,792 shares, compared to its average volume of 1,700,525.

FRANKLIN LAKES, N.J., Oct. 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced it has been named to the 100 Best ...

FRANKLIN LAKES, N.J., Jan. 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its third annual cybersecurity ...

Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based multinational medical device company. On January 24, the company announced a quarterly dividend of $0.91 per share, which was ...FRANKLIN LAKES, N.J., Jan. 6, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that in the interest of the health and safety of its shareholders, directors, officers, employees and meeting attendees in light of the current and ongoing COVID-19 …FRANKLIN LAKES, N.J., Oct. 18, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at helping U.S. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes.FRANKLIN LAKES, N.J., Aug. 22, 2022 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously ...Dec 2, 2021 · FRANKLIN LAKES, N.J., Dec. 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today it has acquired Venclose, Inc., a ... Complete Becton Dickinson & Co. stock information by Barron's. View real-time BDX stock price and news, along with industry-best analysis.Polar Capital Holdings Plc purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) in the second quarter, Holdings Channel.com reports.The institutional ...See the latest Becton Dickinson & Co stock price (BDX:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based medical technology company that mainly specializes in the production of medical devices. In May, Barclays raised its price target on ...FRANKLIN LAKES, N.J., Feb. 23, 2022 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that embecta, the diabetes care business that is expected to spin off from BD on April 1, 2022, will host a virtual Investor Event on March 7, 2022. The event will begin at …Nov 24, 2023 · marketbeat.com - October 10 at 10:16 AM. Close Asset Management Ltd Has $169.95 Million Stake in Becton, Dickinson and Company (NYSE:BDX) marketbeat.com - October 9 at 1:37 PM. Investors in Becton Dickinson (NYSE:BDX) have seen returns of 20% over the past year. uk.style.yahoo.com - October 8 at 3:03 PM. Instagram:https://instagram. can i invest in canadian stocksdoes medicaid pay for braces for adultsbester cfd brokerwhen will openai go public Is BDX stock a buy or sell? The best stock pickers were taking a bullish view. The number of bullish hedge fund positions advanced by 3 lately. Becton, Dickinson and Company (NYSE: BDX) was in 65 ...FRANKLIN LAKES, N.J., Nov. 30, 2023 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, … mortgage companies in delawaredividends and yields The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production....KEYS What a week. Really? What a week !! What a market !! Almost all who trade or invest profes... porsche auction FRANKLIN LAKES, N.J. (Oct. 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced Bridget Bagnato has been named president of BD Specimen Management, effective today. Bagnato will be responsible for driving global strategic, operational, commercial performance and …Dec 1, 2023 · On Friday, Becton Dickinson and Co (BDX:NYQ) closed at 238.89, 4.49% above its 52-week low of 228.62, set on Mar 13, 2023. Data delayed at least 15 minutes, as of Nov 24 2023 18:10 GMT. Latest Becton Dickinson and Co (BDX:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.